BioMarin Eyes Late 2021 Launch As Achondroplasia Drug Succeeds In Phase III

 
• By Mandy Jackson
Red dart arrow hitting in the target center of dartboard with modern city and sunset background. Target business, achieve and victory concept .
Vosoritide hit a near-normal growth velocity mark in Phase III. • Source: Shutterstock

More from Clinical Trials

More from R&D